Company Filing History:
Years Active: 2021
Title: Anuj Khandelwal: Innovator in Pharmaceutical Science
Introduction
Anuj Khandelwal is a notable inventor based in Salt Lake City, Utah. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. His work focuses on improving the efficacy and safety of existing medications.
Latest Patents
Khandelwal holds a patent for "Hybrid Amphotericin B derivatives with reduced toxicity." This patent discloses derivatives of amphotericin B (AmB) that are characterized by improved clinical efficacy and reduced toxicity compared to traditional AmB. The patent also includes pharmaceutical compositions comprising these AmB derivatives, therapeutic methods for their use, and methods for their production.
Career Highlights
Anuj Khandelwal is affiliated with the University of Illinois, where he continues to advance research in pharmaceutical innovations. His work has the potential to significantly impact the treatment of various diseases by providing safer and more effective therapeutic options.
Collaborations
Khandelwal collaborates with esteemed colleagues, including Martin D Burke and Jiabao Zhang, who contribute to his research endeavors and enhance the scope of his work.
Conclusion
Anuj Khandelwal's innovative approach to drug development exemplifies the importance of research in improving healthcare outcomes. His contributions to the field of pharmaceutical science are noteworthy and have the potential to benefit many patients.